PGHL.BO
Procter & Gamble Health Limited
1W: +0.5%
1M: -1.3%
3M: -16.0%
YTD: -7.5%
1Y: -4.5%
3Y: +34.4%
5Y: -17.2%
₹4,939.40 ($52.58)
+91.60 (+1.89%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₹82.0B ($872.8M)
52W Range4727.9-6700
Volume542
Avg Volume621
Beta0.08
Dividend₹45.00
Analyst Ratings
No analyst coverage
Company Info
CEOMilind Vasant Thatte
Employees1,336
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2000-05-25
Websitepghealthindia.com
P&G Plaza
Mumbai 400099
IN
Mumbai 400099
IN
91 22 6866 9000
About Procter & Gamble Health Limited
Procter & Gamble Health Limited engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally. The company provides over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Cosome, Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India BV.
Latest News
No recent news
Recent Insider Trades
No insider trades found